Actively Recruiting

Phase Not Applicable
Age: 50Years - 75Years
MALE
NCT05710861

Cost-utility of Focal HIFU vs Prostatectomy

Led by University Hospital, Bordeaux · Updated on 2026-04-09

346

Participants Needed

20

Research Sites

328 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Medico-Economic Randomized Trial comparing Focal HIFU Treatment to Radical Prostatectomy in Patients with Favorable Intermediate Risk Prostate Cancer

CONDITIONS

Official Title

Cost-utility of Focal HIFU vs Prostatectomy

Who Can Participate

Age: 50Years - 75Years
MALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Male aged 45 to 75 years
  • Diagnosed with non-treated localized prostatic adenocarcinoma with maximum Gleason score 3+4, ISUP 2 unilateral on at most 2 contiguous sextants (favorable intermediate risk)
  • Tumor visible on MRI and confirmed by biopsy
  • Or under active surveillance with unilateral ISUP 2 on at most 2 contiguous sextants
  • Stage T1c or T2
  • PSA less than 20 ng/ml
  • Prostate volume less than 150 ml
  • Patient informed and consents to participate
  • Affiliated with or benefiting from a social security scheme
Not Eligible

You will not qualify if you...

  • Metastatic prostate cancer
  • Gleason score greater than 3+4 (ISUP>2)
  • Presence of cribriform or intraductal adenoma prostate carcinoma
  • Prior treatment for the same cancer
  • Contraindications to pelvic MRI with gadolinium
  • Contraindications to surgery or general anesthesia
  • Refusal of one-year follow-up biopsy after F-HIFU
  • Implants (stent, catheter) less than 1 cm from treatment area
  • Urinary or rectal fistula
  • Anal or rectal stenosis or abnormalities interfering with probe introduction
  • Anatomic abnormalities of rectum or mucosa
  • Presence of urinary artificial sphincter, penile prosthesis, or intraprostatic implant
  • Bladder neck or urethral stenosis or sclerosis
  • Inflammatory bowel disease
  • Ongoing urinary tract infection
  • Previous anal or rectal surgery interfering with probe
  • Latex allergy
  • Rectal wall thickness greater than 10 mm
  • Tumor inaccessible to F-HIFU (fibro-muscular anterior zone)
  • Previous uncontrolled cancer or treated less than 5 years ago (except basal cell skin cancer)
  • Inability to understand trial objectives or adhere to instructions
  • Under legal protection
  • Participation in another ongoing research trial
  • Severe health or psychological problems impairing protocol adherence

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 20 locations

1

Clinique Saint Vincent

Besançon, France, 25000

Actively Recruiting

2

Clinique Tivoli

Bordeaux, France, 33000

Actively Recruiting

3

CHU de Bordeaux

Bordeaux, France, 33076

Actively Recruiting

4

Hopitaux civil de Colmar

Colmar, France, 68024

Withdrawn

5

CHU Grenoble Alpes

Grenoble, France

Actively Recruiting

6

Hopital prive drome ardeche

Guilherand-Granges, France, 07500

Actively Recruiting

7

Hopital Claude HURIEZ

Lille, France, 59000

Actively Recruiting

8

Hopital Privé La Louviere

Lille, France, 59800

Actively Recruiting

9

Hopital Edouard Herriot Pavillon V

Lyon, France, 69437

Actively Recruiting

10

APHM Nord Marseille

Marseille, France, 13015

Actively Recruiting

11

Hopital Cochin

Paris, France, 75014

Actively Recruiting

12

Hopital Privé francheville

Périgueux, France, 204004

Actively Recruiting

13

Hopital Lyon Sud HCL Bat 3C Centre

Pierre-Bénite, France, 69310

Actively Recruiting

14

Clinique La Croix du Sud

Quint-Fonsegrives, France, 31130

Actively Recruiting

15

CHU de Rennes

Rennes, France

Actively Recruiting

16

CH Saintonge

Saint-Jean-d'Angély, France

Actively Recruiting

17

Clinique Saint Michel

Toulon, France, 83100

Actively Recruiting

18

CHU Toulouse rangueil

Toulouse, France, 31400

Actively Recruiting

19

Clinique Oceane

Vannes, France, 56000

Actively Recruiting

20

CHU Pointe à Pitre

Pointe-à-Pitre, Guadeloupe

Not Yet Recruiting

Loading map...

Research Team

F

Franck BLADOU, PROF

CONTACT

G

Grégoire ROBERT, PROF

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here